Philip Ross

Company: Wave Life Sciences Ltd.

Job title: Senior Director - Analytical Development, Quality Control, Chemistry, Manufacturing & Controls

Seminars:

Analytical Control Strategy for a Stereodefined Oligonucleotide Platform: An Integrated Approach from Raw Materials to Drug Substance 10:00 am

• Delve into Wave’s pioneered, stereodefined oligonucleotide chemistry across several  clinically viable modalities • The comprehensive control strategy for stereoisomers that encompasses analytics of  raw materials, processes and finished drug substance • Discussing the range of methodologies supporting the overall stereochemistry control  strategyRead more

day: Day Two AM